WAYNE, Pa., Oct. 1, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Safeguard Scientifics, Inc. (NYSE: SFE ) will be hosting its 8th Annual Investor Day at the New York Stock Exchange on Wednesday, October 15, 2014 from 8:00am–12:15pm EDT.
Investor Day 2014 will offer the investor community an opportunity to hear from Safeguard's executive team along with executives from Safeguard's partner companies about growth opportunities and value creation strategies.
INVESTOR DAY AGENDA – OCTOBER 15, 2014
8:00 a.m.
Registration and Breakfast
8:30 a.m.
Opening Remarks
- John E. Shave III – SVP, Investor Relations and Corporate Communications, Safeguard Scientifics
8:35 a.m.
Safeguard Scientifics
- Stephen T. Zarrilli – President and CEO
- Jeffrey B. McGroarty – SVP and CFO
9:05 a.m.
Good Start Genetics
- Don Hardison, CEO
9:35 a.m.
Spongecell
- Ben Kartzman, Co-Founder and CEO
10:05 a.m.
Apprenda
- Rakesh Malhotra, VP of Products
10:35 a.m.
Putney
- Jean Hoffman, Founder, President and CEO
11:05 a.m.
Medivo
- Sundeep Bhan, Co-Founder and CEO
11:35 a.m.
MediaMath
- Joe Zawadski, Co-Founder and CEO
12:05 p.m.
Closing Remarks followed by Luncheon with Informal Conversation Please note that presenting partner companies and agenda are subject to change. RSVP and ONE-ON-ONES: Please RSVP and submit your one-on-one requests at http://www.safeguard.com/InvestorDay2014 by Friday, October 10th. The following Safeguard executives will be available for one-on-one meetings to discuss Safeguard's portfolio of healthcare and technology companies, in its entirety, along with industry trends and growth opportunities:
- Stephen T. Zarrilli – President and CEO
- Jeffrey B. McGroarty – SVP and CFO
- Gary J. Kurtzman, MD – SVP and Managing Director, Healthcare
- Philip D. Moyer – SVP and Managing Director, Technology
- Erik B. Rasmussen – SVP and Managing Director, Technology
- Al Wiegman – VP and Managing Director, Healthcare
The following partner company executives will be available for one-on-one meetings (alpha order by company name):
- Apprenda – Rakesh Malhotra, VP of Products
- Good Start Genetics – Don Hardison, CEO
- MediaMath – Joe Zawadski, Co-Founder and CEO
- Medivo – Sundeep Bhan, Co-Founder and CEO
- Putney – Jean Hoffman, Founder, President and CEO,
- Spongecell – Ben Kartzman, Co-Founder and CEO
Questions? Please contact us at (610) 975-4944 or IR(at)safeguard(dot)com.
About Safeguard Scientifics
Safeguard Scientifics, Inc. (NYSE: SFE ) has a distinguished track record of fostering innovation and building market leaders. For six decades, Safeguard has been providing growth capital and operational support to entrepreneurs across an evolving spectrum of industries. Today, Safeguard is focused specifically on two sectors--healthcare and technology. Recent successful exits include Alverix (acquired by Becton, Dickinson for $40 million); Crescendo Bioscience (acquired by Myriad Genetics for $270 million); NuPathe (acquired by Teva Pharmaceutical Industries for $144 million); and ThingWorx (acquired by PTC for initial proceeds of $112 million). For more information, please visit http://www.safeguard.com or Follow Us on Twitter @ safeguard .
Forward-looking Statements
Except for the historical information and discussions contained herein, statements contained in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements are subject to risks and uncertainties. The risks and uncertainties that could cause actual results to differ materially include, among others, our ability to make good decisions about the deployment of capital, the fact that our partner companies may vary from period to period, our substantial capital requirements and absence of liquidity from our partner company holdings, fluctuations in the market prices of our publicly traded partner company holdings, competition, our inability to obtain maximum value for our partner company holdings, our ability to attract and retain qualified employees, market valuations in sectors in which our partner companies operate, our inability to control our partner companies, our need to manage our assets to avoid registration under the Investment Company Act of 1940, and risks associated with our partner companies, including the fact that most of our partner companies have a limited history and a history of operating losses, face intense competition and may never be profitable, the effect of economic conditions in the business sectors in which Safeguard's partner companies operate, and other uncertainties described in our filings with the Securities and Exchange Commission. Many of these factors are beyond the Company's ability to predict or control. As a result of these and other factors, the Company's past financial performance should not be relied on as an indication of future performance. The Company does not assume any obligation to update any forward-looking statements or other information contained in this press release.
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/10/prweb12214645.htm
Safeguard Scientifics John E. Shave III +1 610.975.4952
